Koers Alexion Pharmaceuticals, Inc.
Aandelen
ALXN
US0153511094
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01-08-21 |
Chief Tech/Sci/R&D Officer | - | 01-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+27,47% | 659 mld. | |
+27,68% | 557 mld. | |
-4,18% | 359 mld. | |
+16,69% | 322 mld. | |
+9,82% | 297 mld. | |
+6,30% | 215 mld. | |
+4,80% | 210 mld. | |
-6,05% | 200 mld. | |
-8,77% | 149 mld. |